Market Closed -
Other stock markets
|
Pre-market 04:53:28 pm | |||
225 USD | +1.55% |
|
225.6 | +0.26% |
16/07 | Biogen Needs Revenue-Generating Assets to Complete Turnaround, Wedbush Says | MT |
16/07 | Redburn Atlantic Adjusts Price Target on Biogen to $230 From $235, Maintains Neutral Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.04% | 3.28TCr | |
+7.46% | 10TCr | |
+8.42% | 4.23TCr | |
+80.42% | 2.95TCr | |
-10.92% | 1.63TCr | |
+1.93% | 1.44TCr | |
-6.77% | 1.22TCr | |
+177.16% | 1.05TCr | |
-0.97% | 896.68Cr | |
-56.13% | 883.53Cr |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Transcript : Biogen Inc., Q4 2016 Earnings Call, Jan 26, 2017